NEUROGESX Aktie

0,25 EUR 0,3984%

Zu Ihrem Onlinebroker

kaufen verkaufen

NEUROGESX Aktienkurs : 25.05. ( 15 Min. verzögert)
0,252 € Letzter Kurs	0,40% Veränderung	0,251 € Vortag	0,252 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
0,252 - 0,252 Tag	1,82 - 0,238 52 Wochen	0 Tag	0 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

NEUROGESX Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

25.05.

Xenoport: Nearing Decision Day

NeurogesX Inc.'s (NGSX) Qutenza (capsaicin) 8% patch, a dermal delivery system , is also an FDA-approved product for the management of neuropathic pain due to PHN. Xenoport, which discovered and …
24.05.

NeurogesX (NGSX) Could Be Poised For A Comeback

NeurogesX Inc. (NASDAQ: NGSX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies to address unmet medical needs a…

24.05.

NeurogesX (NGSX) Could Be Poised For A Comeback

NeurogesX Inc. (NASDAQ: NGSX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies to address unmet medical needs a…
03.05.

U.S. Companies Reporting Negative EPS Surprises, May 3

... OXF OXFORD RESOURCE -0.32 -0.07 -357.1 -0.22 -45.5 -0.21 -2.19 IPCC INFINITY PROPERT 0.36 0.63 -42.9 0.61 -41.0 -2.50 -4.59 NGSX# NEUROGESX INC -0.31 ...
03.05.

NeurogesX Reports First Quarter 2012 Results

SAN MATEO, Calif., May 3, 2012 (GLOBE NEWSWIRE) -- NeurogesX, Inc. (NASDAQ:NGSX) , a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies,...